NAD+ (nicotinamide adenine dinucleotide) is the single most studied molecule in modern longevity research — a coenzyme present in every living cell that serves as the essential substrate for cellular energy production, DNA repair, and the activation of sirtuins, the enzyme family most closely associated with aging biology.

NAD+ (nicotinamide adenine dinucleotide) is the single most studied molecule in modern longevity research — a coenzyme present in every living cell that serves as the essential substrate for cellular energy production, DNA repair, and the activation of sirtuins, the enzyme family most closely associated with aging biology. Published research demonstrates that cellular levels decline by approximately 50% between young adulthood and age 60 in human tissue, and this decline correlates directly with reduced mitochondrial function, impaired DNA repair capacity, and the progression of age-related metabolic disease.

Unlike traditional peptides, this coenzyme is a dinucleotide — two nucleotides joined through their phosphate groups. But its position at the intersection of cellular metabolism, genome maintenance, and epigenetic regulation has made it one of the most actively investigated molecules in the research peptide and longevity space. A 2026 PRISMA-guided systematic review published in Ageing Research Reviews identified 113 eligible studies — 33 human intervention trials and 80 rodent studies — evaluating NAD+-related compounds, confirming the depth and breadth of research activity. PSPeptides offers research-grade NAD+ for laboratory applications studying cellular metabolism and aging biology.

How Does NAD+ Work in Cellular Metabolism?

The coenzyme functions through two fundamentally different biochemical roles — and understanding both is essential for grasping why its decline with age is so consequential.

Role 1 — Redox coenzyme: It acts as an electron carrier in hundreds of metabolic reactions, shuttling electrons (as hydrogen atoms) between metabolic intermediates. In glycolysis, the tricarboxylic acid (TCA) cycle, and oxidative phosphorylation, the coenzyme accepts electrons to become NADH, which then donates those electrons to the mitochondrial electron transport chain to drive ATP production. This redox cycling is reversible — the two forms interconvert continuously without net consumption. Every cell in the body requires this shuttle for energy production.

Role 2 — Consumable substrate: This is the role that makes cellular levels decline with age. Several enzyme families — PARPs (poly-ADP-ribose polymerases), sirtuins (SIRT1-7), and CD38/CD157 — consume it as a substrate, breaking it apart in the process. Unlike the reversible redox cycling, these reactions permanently consume the coenzyme and release nicotinamide (NAM) as a byproduct. When DNA damage accumulates (triggering PARP activation), when sirtuin activity increases (for gene regulation and stress response), or when CD38 expression rises (as it does with aging-related inflammation), it is consumed faster than it can be replenished. The result is a progressive decline in the total cellular pool.

This dual role creates a metabolic competition. DNA repair (via PARPs) and gene regulation (via sirtuins) both require the coenzyme — but when its levels fall, both functions are impaired simultaneously. Published research shows that low cellular levels slow DNA repair by up to 40%, while also reducing sirtuin-mediated gene silencing and metabolic regulation. This creates a vicious cycle: accumulated DNA damage triggers PARP activation, which consumes it, which reduces sirtuin function, which impairs cellular stress responses, which leads to more DNA damage.

Why Do NAD+ Levels Decline with Age?

The age-related decline is one of the most reproducible findings in aging biology. Published studies in both animal models and human tissue consistently show that cellular levels in a 60-year-old may be roughly half of what they were at age 20. Several mechanisms drive this decline.

CD38 upregulation: CD38 is an ectoenzyme that degrades the coenzyme and its precursors. CD38 expression increases with aging-related inflammation (inflammaging), and research has demonstrated that CD38 is the primary driver of age-related decline in multiple tissues. Genetic deletion of CD38 in animal models prevents this age-related decline entirely, confirming its central role.

Increased PARP activity: As DNA damage accumulates with age (from oxidative stress, environmental exposures, and replication errors), PARP enzymes are activated more frequently and for longer durations. Each activation event consumes multiple molecules of the coenzyme. Published research from the National Institutes of Health has shown that excessive PARP activation can drain cellular reserves to the point of triggering energy crisis and cell death.

Reduced biosynthesis: The salvage pathway — which recycles nicotinamide back into the coenzyme via the enzyme NAMPT (nicotinamide phosphoribosyltransferase) — becomes less efficient with age. NAMPT expression declines in multiple tissues, reducing the rate at which consumed molecules can be regenerated.

The convergence of increased consumption (CD38 + PARP) and decreased regeneration (reduced NAMPT) produces the progressive deficit that characterizes biological aging. For researchers studying the broader landscape of aging biology, our best peptides for longevity guide covers how compounds like epitalon, MOTS-C, and GHK-Cu address different hallmarks of aging through complementary mechanisms.

For broader authoritative context on aging biology and the cellular mechanisms underlying age-related decline, the NIH National Institute on Aging Division of Aging Biology provides comprehensive resources on the biological hallmarks of aging and current research priorities in the field.

NAD+ and Sirtuins: The Longevity Enzyme Connection

The sirtuin family (SIRT1-7) represents the most direct mechanistic link between cellular NAD+ and aging biology. Sirtuins are NAD+-dependent deacetylases and ADP-ribosyltransferases that regulate gene expression, mitochondrial function, inflammation, and cellular stress responses. Without adequate coenzyme, sirtuins cannot function — making its availability a rate-limiting factor for sirtuin activity.

SIRT1 (nuclear) regulates gene silencing, inflammatory pathways (NF-κB suppression), glucose metabolism, and fat mobilization. Reduced SIRT1 activity is associated with metabolic syndrome, insulin resistance, and accelerated aging.

SIRT3 (mitochondrial) regulates mitochondrial protein acetylation, antioxidant defenses (activating SOD2), and fatty acid oxidation. Reduced SIRT3 activity impairs mitochondrial function and increases oxidative stress — connecting this decline directly to the mitochondrial dysfunction hallmark of aging. For researchers studying mitochondrial peptides, MOTS-C activates AMPK metabolic signaling, while the coenzyme supports sirtuin-mediated mitochondrial protein regulation — complementary mechanisms for addressing mitochondrial decline.

SIRT6 (nuclear) is essential for DNA damage repair and telomere maintenance. SIRT6 deacetylates histone H3K9 and H3K56, facilitating access for DNA repair proteins to damaged genomic sites. Reduced SIRT6 activity accelerates genomic instability. Researchers studying telomere biology may also be interested in epitalon, which activates telomerase through a different mechanism than sirtuin-mediated telomere maintenance.

The coenzyme-sirtuin axis is remarkable in aging research because it intersects with multiple hallmarks of aging simultaneously: genomic instability (PARP/SIRT-mediated DNA repair), epigenetic alterations (sirtuin-dependent histone deacetylation), mitochondrial dysfunction (SIRT3 regulation), and altered nutrient sensing (SIRT1 metabolic regulation). This multi-hallmark intersection explains why the molecule has attracted more longevity research attention than virtually any other single molecule.

What Does the Human Clinical Evidence Show?

The 2026 PRISMA-guided systematic review in Ageing Research Reviews provides the most comprehensive assessment of human research to date. It evaluated 33 human intervention studies (28 randomized, 5 nonrandomized) using related compounds — primarily oral NR (nicotinamide riboside) and NMN (nicotinamide mononucleotide) as precursors, as well as direct administration.

Biochemical target engagement: The evidence for raising levels in humans is strong. Oral NR and NMN consistently demonstrated increases in circulating metabolites in blood and cellular compartments (PBMCs — peripheral blood mononuclear cells). This confirms that supplementation successfully increases the cellular pool in human tissue.

Functional outcomes: The clinical picture is more heterogeneous. Effects on functional, metabolic, vascular, and other healthspan-relevant endpoints were described as “heterogeneous and often null or endpoint-specific.” Some studies showed improvements in specific metabolic markers, while others found no significant functional changes despite confirmed elevation. A randomized, double-blind, placebo-controlled study found that a novel supporting supplement increased cellular levels and improved self-reported well-being and aging symptoms — suggesting functional benefits that may require specific measurement approaches to detect.

Safety: Both oral precursors and direct administration were “generally well tolerated over weeks to months” across the reviewed studies, with no serious adverse events attributable to supplementation. This favorable safety profile supports continued research into longer-duration protocols and higher doses.

Cardiovascular implications: A separate body of research has examined the coenzyme in the context of cardiovascular health. A review published in Frontiers in Cardiovascular Medicine systematically summarized the impact of NMN supplementation on cardiovascular diseases, finding that augmentation alleviated the development of conditions including heart failure, atherosclerosis, and myocardial ischemia-reperfusion injury in preclinical models. The mechanism involves coenzyme-dependent PARP activity for cardiac DNA repair and SIRT3-mediated mitochondrial protein regulation in cardiomyocytes — which are among the most mitochondria-dense cells in the body. For researchers studying cardiac mitochondrial biology, our SS-31 (elamipretide) guide covers a peptide that protects cardiac mitochondria through cardiolipin stabilization rather than enzyme-dependent support.

Skin anti-aging: This research has also extended into cosmetic dermatology. A 2025 study evaluated a liposomal formulation in primary human endothelial cells and keratinocytes, finding enhanced anti-senescence properties compared to unencapsulated forms. The liposomal delivery improved intracellular uptake and more effectively reduced senescence-associated beta-galactosidase staining — a marker of cellular aging. This connects the research to the cosmetic peptide space where compounds like GHK-Cu and other skin peptides address aging through different mechanisms.

NAD+ vs NMN vs NR: Understanding the Precursor Landscape

Researchers and consumers frequently encounter three related molecules — NAD+ itself, NMN, and NR — and understanding the differences is essential for designing appropriate research protocols.

The tradeoff is straightforward: smaller precursors (NR, NMN) have better oral bioavailability but require enzymatic conversion to become active. Direct supplementation delivers the functional molecule itself but faces bioavailability challenges due to its larger molecular size — particularly through oral routes. This is why the direct form is commonly administered via IV infusion, subcutaneous injection, or sublingual absorption rather than orally.

PSPeptides’ NAD+ provides the direct coenzyme for research applications that study the compound’s biology without the confounding variable of precursor conversion efficiency. For researchers interested in how preservation relates to other metabolic interventions, 5-Amino-1MQ inhibits NNMT — an enzyme that depletes the precursor pool by methylating nicotinamide — creating a mechanistic connection between NNMT inhibition and coenzyme maintenance.

NAD+ and the Multiple Hallmarks of Aging

What makes the molecule exceptional in aging research is the number of recognized hallmarks of aging it intersects with simultaneously. The widely cited “Hallmarks of Aging” framework, published in Cell by López-Otín et al., identifies nine core hallmarks. Its decline is mechanistically connected to at least five of them.

Genomic instability: The coenzyme is consumed by PARP enzymes during DNA damage repair. Low levels impair PARP function, allowing DNA damage to accumulate and reducing genomic stability.

Epigenetic alterations: Sirtuins (SIRT1, SIRT6) catalyze coenzyme-dependent histone deacetylation, maintaining the epigenetic marks that regulate gene expression patterns. Depletion disrupts these epigenetic controls.

Mitochondrial dysfunction: The coenzyme is required for electron transport chain function (as NADH), and SIRT3-mediated mitochondrial protein regulation requires it as substrate. Researchers studying mitochondrial peptides like MOTS-C will recognize how depletion connects to the bioenergetic decline that MOTS-C addresses through AMPK activation.

Deregulated nutrient sensing: SIRT1 is a master regulator of nutrient sensing pathways, modulating insulin signaling, gluconeogenesis, and fat metabolism. Depletion impairs SIRT1 function and disrupts metabolic homeostasis.

Cellular senescence: Depletion promotes cellular senescence through multiple mechanisms including impaired DNA repair, reduced sirtuin-mediated stress responses, and metabolic dysfunction. Research has shown that supplementation can reduce markers of cellular senescence in both cell culture and animal models. A liposomal formulation study demonstrated enhanced anti-senescence properties in human endothelial cells and keratinocytes compared to unencapsulated forms.

This multi-hallmark intersection is why it has attracted more longevity research attention than virtually any other single molecule. No other compound simultaneously addresses genomic instability, epigenetic regulation, mitochondrial function, nutrient sensing, and cellular senescence through a single mechanistic node. This age-related decline doesn’t just correlate with aging — it mechanistically contributes to multiple aging processes simultaneously, creating a cascade of dysfunction that feeds on itself as cellular levels continue to fall.

NAD+ Research Protocols and Handling

The coenzyme is supplied as a lyophilized powder requiring reconstitution for research applications. Reconstitute with bacteriostatic water using standard aseptic technique as described in our reconstitution guide. It is relatively stable in lyophilized form when stored at -20°C protected from light and moisture. Once reconstituted, solutions should be refrigerated and used promptly, as the compound in solution is susceptible to hydrolysis. See our storage guide for detailed handling protocols.

For dosing calculations involving mass-to-volume conversions, our peptide calculator guide covers the standard approach. Research protocols vary widely depending on the application — IV infusion studies in clinical settings have used 250-1000 mg doses, while subcutaneous research protocols typically use lower doses appropriate to the specific investigation.

This research intersects with several other compounds available from PSPeptides. The mechanistic connection to 5-Amino-1MQ (which preserves the precursor pool by inhibiting NNMT) creates a natural research pairing for studies examining coenzyme homeostasis from complementary angles. Researchers studying the broader mitochondrial function landscape may combine these investigations with MOTS-C (AMPK-mediated mitochondrial signaling) or reference the SS-31 mechanism (cardiolipin stabilization) to understand how different interventions address mitochondrial health through distinct molecular targets. The comprehensive picture of mitochondrial aging requires understanding how substrate availability, membrane structure (SS-31/cardiolipin), and metabolic signaling (MOTS-C/AMPK) each contribute independently.

Further Reading

For additional peer-reviewed research, see: Hallmarks of Aging published in Cell (López-Otín et al.).

Understanding nad+ is essential for researchers navigating this rapidly evolving field in 2026.

Frequently Asked Questions

What is NAD+ and why does it matter for aging?

NAD+ is a coenzyme present in every cell that is essential for energy production (ATP synthesis), DNA repair (PARP activation), and gene regulation (sirtuin activation). NAD+ levels decline approximately 50% between ages 20 and 60 in human tissue, which impairs all three functions simultaneously — making NAD+ decline one of the most significant molecular changes associated with biological aging.

What is the difference between NAD+, NMN, and NR?

NAD+ is the active coenzyme itself. NMN (nicotinamide mononucleotide) is a direct precursor that requires one enzymatic step to become NAD+. NR (nicotinamide riboside) requires two enzymatic steps. Smaller precursors have better oral bioavailability but require conversion. Direct NAD+ delivers the functional molecule but is typically administered via injection or IV due to its larger molecular size.

Can NAD+ reverse aging?

Published rodent studies show that NAD+ augmentation improves metabolic, mitochondrial, and inflammatory markers associated with aging. Human clinical data confirms NAD+ levels can be successfully elevated through supplementation. However, the 2026 PRISMA systematic review found that functional healthspan outcomes in humans are “heterogeneous and often null or endpoint-specific” — meaning NAD+ supplementation consistently raises NAD+ levels but does not consistently translate into measurable functional improvements across all endpoints studied.

How does NAD+ relate to other longevity peptides?

NAD+ addresses aging through metabolic and DNA repair mechanisms that complement rather than duplicate peptide-based approaches. Epitalon targets telomere maintenance, MOTS-C targets mitochondrial signaling via AMPK, and GHK-Cu targets tissue regeneration through gene expression modulation. Each addresses different hallmarks of aging.

All PSPeptides products are sold exclusively for research and laboratory use.